[go: up one dir, main page]

ECSP034851A - Derivados imidazo[1,5-a]pirimido[5,4-d]benzazepina como moduladores del receptor gaba a - Google Patents

Derivados imidazo[1,5-a]pirimido[5,4-d]benzazepina como moduladores del receptor gaba a

Info

Publication number
ECSP034851A
ECSP034851A EC2003004851A ECSP034851A ECSP034851A EC SP034851 A ECSP034851 A EC SP034851A EC 2003004851 A EC2003004851 A EC 2003004851A EC SP034851 A ECSP034851 A EC SP034851A EC SP034851 A ECSP034851 A EC SP034851A
Authority
EC
Ecuador
Prior art keywords
lower alkyl
gaba
benzazepina
pyrimid
cycloalkyl
Prior art date
Application number
EC2003004851A
Other languages
English (en)
Inventor
Jurgen Wichmann
Raffaello Masciadri
Andrew William Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ECSP034851A publication Critical patent/ECSP034851A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula en donde R1 es halógeno o alquilo inferior; R2 es hidrógeno, alquilo inferior, cicloalquilo, -(CH2)m-fenilo, en donde el anillo fenilo puede estar sustituido por alcoxilo inferior, o es -(CH2)m-indolilo; R3 es -C(0) O-alquilo inferior, -C(0) OH, o un grupo heteroaromático de cinco miembros, cuyos anillos pueden estar sustituidos por alquilo inferior o cicloalquilo; n es 0, 1 ó 2; m es 0, 1 ó 2; y sus sales de adición ácida farmacéuticamente aceptables. Se ha descubierto que esta clase de compuestos muestran una elevada afinidad y selectividad para los sitios de unión del receptor a5 de GABA A y pueden ser útiles para el tratamiento de mejoras cognitivas o de trastornos cognitivos como la enfermedad de Alzheimer.
EC2003004851A 2001-05-18 2003-11-17 Derivados imidazo[1,5-a]pirimido[5,4-d]benzazepina como moduladores del receptor gaba a ECSP034851A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18

Publications (1)

Publication Number Publication Date
ECSP034851A true ECSP034851A (es) 2003-12-24

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004851A ECSP034851A (es) 2001-05-18 2003-11-17 Derivados imidazo[1,5-a]pirimido[5,4-d]benzazepina como moduladores del receptor gaba a

Country Status (38)

Country Link
US (1) US6686352B2 (es)
EP (1) EP1399448B1 (es)
JP (1) JP4068466B2 (es)
KR (1) KR100533406B1 (es)
CN (1) CN1230436C (es)
AR (1) AR033753A1 (es)
AT (1) ATE283857T1 (es)
AU (1) AU2002338898B2 (es)
BG (1) BG108369A (es)
BR (1) BR0209859A (es)
CA (1) CA2446903C (es)
CZ (1) CZ20033355A3 (es)
DE (1) DE60202147T2 (es)
DK (1) DK1399448T3 (es)
EC (1) ECSP034851A (es)
ES (1) ES2232778T3 (es)
GT (1) GT200200087A (es)
HK (1) HK1066544A1 (es)
HR (1) HRP20030890A2 (es)
HU (1) HUP0400743A3 (es)
IL (2) IL158572A0 (es)
JO (1) JO2297B1 (es)
MA (1) MA27024A1 (es)
MX (1) MXPA03010529A (es)
MY (1) MY127570A (es)
NO (1) NO20035104L (es)
NZ (1) NZ529097A (es)
PA (1) PA8545201A1 (es)
PE (1) PE20030041A1 (es)
PL (1) PL366846A1 (es)
PT (1) PT1399448E (es)
RU (1) RU2287531C2 (es)
SI (1) SI1399448T1 (es)
SK (1) SK15252003A3 (es)
TW (1) TWI251489B (es)
WO (1) WO2002094834A1 (es)
YU (1) YU90003A (es)
ZA (1) ZA200308544B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120091275A (ko) 2004-05-14 2012-08-17 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 방법
EP1799684B1 (en) * 2004-10-04 2014-12-03 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
MX2007004640A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de benzodiazepina sustituidos con halogeno.
MX2007004639A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de imidazo-benzodiazepina.
AU2006301377B2 (en) * 2005-10-11 2012-03-08 F. Hoffmann-La Roche Ag Imidazo benzodiazepine derivatives
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2008003749A1 (es) 2007-12-17 2010-01-15 Janssen Pharmaceutica Nv Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras.
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
JP5684719B2 (ja) * 2008-12-05 2015-03-18 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Plk阻害剤としての5,7−ジヒドロ−6h−ピリミド[5、−4d][1]ベンゾアゼピン−6−チオン
EP2376082B1 (en) 2008-12-22 2014-03-05 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-cd20 antibodies
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
JP2013520424A (ja) 2010-02-19 2013-06-06 ミレニアム ファーマシューティカルズ, インコーポレイテッド ナトリウム4−{[9−クロロ−7−(2−フルオロ−6−メトキシフェニル)−5H−ピリミド[5,4−d][2]ベンゾアゼピン−2−イル]アミノ}−2−メトキシベンゾエートの結晶形
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
CN105209042B (zh) 2013-03-22 2019-03-08 米伦纽姆医药公司 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合
AU2014368961B2 (en) 2013-12-20 2019-10-17 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2016205739A1 (en) 2015-06-19 2016-12-22 Belew Mekonnen Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
EP3324976A4 (en) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2019246300A1 (en) 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201311B (es) 1991-06-17 1993-03-01 Hoffmann La Roche
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
US6511987B1 (en) 1999-11-12 2003-01-28 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
ZA200308544B (en) 2005-01-31
JP2004531563A (ja) 2004-10-14
ES2232778T3 (es) 2005-06-01
NO20035104D0 (no) 2003-11-17
SK15252003A3 (sk) 2004-08-03
CN1230436C (zh) 2005-12-07
PE20030041A1 (es) 2003-02-07
MY127570A (en) 2006-12-29
EP1399448A1 (en) 2004-03-24
AU2002338898B8 (en) 2002-12-03
US20030055042A1 (en) 2003-03-20
IL158572A0 (en) 2004-05-12
PT1399448E (pt) 2005-03-31
PL366846A1 (en) 2005-02-07
CZ20033355A3 (en) 2004-07-14
ATE283857T1 (de) 2004-12-15
HK1066544A1 (en) 2005-03-24
HUP0400743A2 (hu) 2004-07-28
DK1399448T3 (da) 2005-04-11
BR0209859A (pt) 2004-06-15
RU2003136078A (ru) 2005-05-27
US6686352B2 (en) 2004-02-03
IL158572A (en) 2010-02-17
KR100533406B1 (ko) 2005-12-02
GT200200087A (es) 2003-06-19
SI1399448T1 (en) 2005-02-28
CA2446903A1 (en) 2002-11-28
JP4068466B2 (ja) 2008-03-26
RU2287531C2 (ru) 2006-11-20
AR033753A1 (es) 2004-01-07
HUP0400743A3 (en) 2007-09-28
MA27024A1 (fr) 2004-12-20
JO2297B1 (en) 2005-09-12
PA8545201A1 (es) 2003-02-28
DE60202147D1 (de) 2005-01-05
HRP20030890A2 (en) 2005-08-31
WO2002094834A1 (en) 2002-11-28
DE60202147T2 (de) 2005-12-01
TWI251489B (en) 2006-03-21
AU2002338898B2 (en) 2007-03-15
BG108369A (bg) 2005-01-31
YU90003A (sh) 2006-08-17
CA2446903C (en) 2008-12-30
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
NO20035104L (no) 2003-11-17
KR20040002975A (ko) 2004-01-07
EP1399448B1 (en) 2004-12-01
CN1509289A (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
ECSP034851A (es) Derivados imidazo[1,5-a]pirimido[5,4-d]benzazepina como moduladores del receptor gaba a
CR6165A (es) Procedimientos e intermedios para preparar compuestos anticancerosos
PE20030129A1 (es) Imidazotriazinas
WO2017096301A1 (en) Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (ripk 1)
PA8522001A1 (es) Pro - farmacos de derivados de 4- fenil - piridin.
MX2007006896A (es) Fenil-metanonas bi- y triciclicas sustituidas como inhibidores del transportador 1 de glicina (glyt-1) para el tratamiento de la enfermedad de alzheimer.
AR046186A1 (es) Compuestos derivados de 1,3,8-triaza-espiro[4.5]decan-4-ona
WO2007022934A3 (en) Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors
RU2007111757A (ru) Амидные производные 3-фенилдигидропиримидо [4,5-d] пиримидинонов, их получение и использованиев качестве фармацевтических агентов
PH12012500690A1 (en) Positive allosteric modulators (pam)
AR036233A1 (es) Un compuesto derivado de indol, su uso, procesos para prepararlo y una composicion farmaceutica que lo comprende
SE0202134D0 (sv) Therapeutic agents
ATE455113T1 (de) 3-triazolylthioalkyl-3-azabicyclo ä3.1.0ühexane und ihre verwendung als liganden des dopamin-d3- rezeptors
WO2007054444A3 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
ATE420859T1 (de) Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren
AR040489A1 (es) Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen
EA200700572A1 (ru) Соединение 2-морфолино-4-пиримидона
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
TW200630372A (en) Imidazo-benzodiazepine derivatives
MX2007004250A (es) Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos.
PE20060630A1 (es) Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie
TW200631953A (en) Tetracyclic imidazo-benzodiazepines
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
ES2000524A6 (es) Procedimiento para la preparacion de nuevas benzamidas y benzoatos sustituidos.
YU18404A (sh) Hemijska jedinjenja